#guidelinesuterinecancer2021

[universitycancercentres]

NCCN GUIDELINES ON UTERINE NEOPLASMS

Researchers forecasted it would pinpoint approximately 66,570 new cases of uterine cancer or tumor cases in the United States in 2021, and around 12,940 patients would die from the disease. Most of the uterine cancers are epithelial-derived and develop in the endometrium (endometrial carcinoma). Mesenchymal or stromal sarcomas are abnormal cancer tumors, accounting for around 3% of all uterine cancers. Uterine sarcomas include high-grade and low-grade endometrial stromal sarcoma (HGESS and LGESS, respectively), rhabdomyosarcoma (RMS), undifferentiated uterine sarcoma (UUS), uterine leiomyosarcoma (ULMS) including epithelioid and myxoid variants, uterine tumor resembling ovarian sex cord tumor (UTROSCT), and perivascular epithelioid cell tumors (PEComas).

Read more:- guidelines uterine cancer 2021